1. Home
  2. RDY vs IHS Comparison

RDY vs IHS Comparison

Compare RDY & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • IHS
  • Stock Information
  • Founded
  • RDY 1984
  • IHS 2001
  • Country
  • RDY India
  • IHS United Kingdom
  • Employees
  • RDY N/A
  • IHS N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • IHS Telecommunications Equipment
  • Sector
  • RDY Health Care
  • IHS Telecommunications
  • Exchange
  • RDY Nasdaq
  • IHS Nasdaq
  • Market Cap
  • RDY 2.1B
  • IHS 1.9B
  • IPO Year
  • RDY N/A
  • IHS 2021
  • Fundamental
  • Price
  • RDY $14.53
  • IHS $5.96
  • Analyst Decision
  • RDY Strong Buy
  • IHS Strong Buy
  • Analyst Count
  • RDY 2
  • IHS 6
  • Target Price
  • RDY $16.95
  • IHS $9.75
  • AVG Volume (30 Days)
  • RDY 1.5M
  • IHS 900.6K
  • Earning Date
  • RDY 07-28-2025
  • IHS 08-12-2025
  • Dividend Yield
  • RDY 0.56%
  • IHS N/A
  • EPS Growth
  • RDY 1.47
  • IHS N/A
  • EPS
  • RDY 0.79
  • IHS N/A
  • Revenue
  • RDY $3,809,801,863.00
  • IHS $1,733,125,000.00
  • Revenue This Year
  • RDY $10.24
  • IHS $0.63
  • Revenue Next Year
  • RDY N/A
  • IHS $4.82
  • P/E Ratio
  • RDY $18.39
  • IHS N/A
  • Revenue Growth
  • RDY 16.61
  • IHS N/A
  • 52 Week Low
  • RDY $12.26
  • IHS $2.44
  • 52 Week High
  • RDY $16.89
  • IHS $6.43
  • Technical
  • Relative Strength Index (RSI)
  • RDY 37.98
  • IHS 52.82
  • Support Level
  • RDY $14.81
  • IHS $5.40
  • Resistance Level
  • RDY $15.25
  • IHS $6.27
  • Average True Range (ATR)
  • RDY 0.20
  • IHS 0.26
  • MACD
  • RDY -0.12
  • IHS 0.02
  • Stochastic Oscillator
  • RDY 5.18
  • IHS 54.37

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About IHS IHS Holding Limited

IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.

Share on Social Networks: